Search research articles
Contact Us
Filters
Showing results (161-170 of 218) with videos related to
Page
of 22
Sort By:
British Journal of Haematology
|
October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia
Fiona C Brown, Paolo Cifani, Esther Drill, et al.
The Lancet. Oncology
|
May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
British Journal of Haematology
|
September 24, 2023
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias
Catherine Mark, Soheil Meshinchi, Brooklyn Joyce, et al.
Clinical Epigenetics
|
October 17, 2017
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
Lia Gore, Timothy J Triche, Jason E Farrar, et al.
Blood
|
May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group
Katherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Cancers
|
April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report
Fabiana Ostronoff, Megan Othus, Michelle Lazenby, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
Emilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Biomarker Research
|
March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
Page
of 22
Search research articles
Search
Showing results (161-170 of 218) with videos related to
Sort By:
Page
of 22
British Journal of Haematology
|
October 22, 2016
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia
Fiona C Brown, Paolo Cifani, Esther Drill, et al.
The Lancet. Oncology
|
May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Jeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
British Journal of Haematology
|
September 24, 2023
Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias
Catherine Mark, Soheil Meshinchi, Brooklyn Joyce, et al.
Clinical Epigenetics
|
October 17, 2017
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
Lia Gore, Timothy J Triche, Jason E Farrar, et al.
Blood
|
May 5, 2021
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group
Katherine Tarlock, Adam J Lamble, Yi-Cheng Wang, et al.
Cancers
|
April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial
Anneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2015
Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report
Fabiana Ostronoff, Megan Othus, Michelle Lazenby, et al.
Blood
|
September 22, 2020
Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report
Fieke W Hoff, Anneke D van Dijk, Yihua Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2017
MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
Emilia L Lim, Diane L Trinh, Rhonda E Ries, et al.
Biomarker Research
|
March 17, 2023
Verification of prognostic expression biomarkers is improved by examining enriched leukemic blasts rather than mononuclear cells from acute myeloid leukemia patients
Era L Pogosova-Agadjanyan, Xing Hua, Megan Othus, et al.
Page
of 22